News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,190 Results
Type
Article (14434)
Company Profile (114)
Press Release (349642)
Section
Business (112624)
Career Advice (456)
Deals (18610)
Drug Delivery (28)
Drug Development (31173)
Employer Resources (50)
FDA (8793)
Job Trends (7672)
News (172740)
Policy (12355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1321)
Accelerated approval (2)
Allergies (39)
Alliances (34778)
ALS (22)
Alzheimer's disease (508)
Antibody-drug conjugate (ADC) (63)
Approvals (8815)
Artificial intelligence (230)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (12)
Breast cancer (111)
Cancer (954)
Cardiovascular disease (60)
Career advice (406)
Career pathing (8)
CAR-T (98)
Cell therapy (258)
Cervical cancer (10)
Clinical research (24437)
Collaboration (568)
Compensation (105)
Complete response letters (3)
COVID-19 (1147)
CRISPR (34)
C-suite (131)
Cystic fibrosis (47)
Data (919)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (93)
Diagnostics (4899)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (74)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38578)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51155)
Executive appointments (367)
FDA (9378)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (450)
Gene editing (81)
Generative AI (23)
Gene therapy (162)
GLP-1 (222)
Government (1233)
Grass and pollen (2)
Guidances (24)
Healthcare (9891)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (28)
Indications (11)
Infectious disease (1218)
Inflammatory bowel disease (61)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (51)
IPO (8003)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (116)
Leadership (3)
Legal (2521)
Liver cancer (34)
Lung cancer (121)
Lymphoma (56)
Machine learning (2)
Management (17)
Manufacturing (167)
MASH (15)
Medical device (11458)
Medtech (11463)
Mergers & acquisitions (10934)
Metabolic disorders (201)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (689)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1040)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (47)
Pancreatic cancer (38)
Parkinson's disease (65)
Partnered (11)
Patents (129)
Patient recruitment (51)
Peanut (26)
People (32687)
Pharmaceutical (16)
Phase I (9010)
Phase II (11027)
Phase III (7155)
Pipeline (506)
Podcasts (37)
Policy (27)
Postmarket research (501)
Preclinical (4066)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (133)
Real estate (3359)
Recruiting (20)
Regulatory (9340)
Reports (18)
Research institute (1269)
Resumes & cover letters (68)
Rett syndrome (3)
RNA editing (2)
RSV (21)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1127)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (2)
Supply chain (23)
The Weekly (18)
United States (10887)
Vaccines (310)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (56)
Last 7 days (317)
Last 30 days (1336)
Last 365 days (17644)
2025 (4319)
2024 (18710)
2023 (22100)
2022 (30813)
2021 (32513)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (119)
Arkansas (10)
Asia (24006)
Australia (4182)
California (2714)
Canada (987)
China (228)
Colorado (155)
Connecticut (126)
Delaware (39)
Europe (49050)
Florida (443)
Georgia (131)
Idaho (33)
Illinois (266)
India (11)
Indiana (153)
Iowa (4)
Japan (101)
Kansas (81)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (434)
Massachusetts (1904)
Michigan (179)
Minnesota (240)
Mississippi (2)
Missouri (57)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (856)
New Mexico (16)
New York (807)
North Carolina (506)
North Dakota (7)
Northern California (1040)
Ohio (99)
Oklahoma (11)
Oregon (19)
Pennsylvania (555)
Puerto Rico (7)
Rhode Island (21)
South America (505)
South Carolina (16)
South Dakota (1)
Southern California (1127)
Tennessee (57)
Texas (438)
Utah (99)
Virginia (53)
Washington D.C. (11)
Washington State (314)
West Virginia (3)
Wisconsin (35)
364,190 Results for "axosim technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
AxoSim Extends Leadership in Human Organoids for Neurological Drug Discovery with Acquisition of StemoniX microBrain™ Technology
AxoSim, Inc. announced completion of its acquisition of the microBrain™ associated assets of Vyant Bio’s StemoniX subsidiary.
October 24, 2023
·
5 min read
Deals
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets
AxoSim, Inc., a leader in the development and application of human biomimetic platforms for neurological diseases, and Vyant Bio, Inc. (OTC: VYNT) (Vyant Bio) today announced that they have entered into a definitive agreement under which AxoSim will acquire the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary.
July 17, 2023
·
9 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology
March 26, 2025
·
3 min read
Press Releases
Nirrin Technologies Granted Patent for Cutting-Edge Flow-Cell Technology, Advancing Real-time Bioprocess Monitoring
March 26, 2025
·
2 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Press Releases
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
April 2, 2025
·
4 min read
Press Releases
Clene to Present at the Jones Healthcare and Technology Innovation Conference
April 1, 2025
·
1 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Artificial intelligence
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
January 7, 2025
·
2 min read
·
Tristan Manalac
1 of 36,419
Next
